These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6708977)

  • 1. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol.
    Pietro DA; LaBresh KA; Shulman RM; Folland ED; Parisi AF; Sasahara AA
    N Engl J Med; 1984 Apr; 310(16):1032-4. PubMed ID: 6708977
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary pulmonary hypertension; favorable effect of isoproterenol.
    Shettigar UR; Hultgren HN; Specter M; Martin R; Davies DH
    N Engl J Med; 1976 Dec; 295(25):1414-5. PubMed ID: 980096
    [No Abstract]   [Full Text] [Related]  

  • 3. Sublingual isoproterenol for primary pulmonary hypertension.
    Hogan RA
    N Engl J Med; 1984 Aug; 311(8):538. PubMed ID: 6749216
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral tadalafil in pulmonary artery hypertension: a prospective study.
    Aggarwal P; Patial RK; Negi PC; Marwaha R
    Indian Heart J; 2007; 59(4):329-35. PubMed ID: 19126938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.
    Ackroyd JF
    J R Soc Med; 1985 Jun; 78(6):474-7. PubMed ID: 3999084
    [No Abstract]   [Full Text] [Related]  

  • 6. Diazoxide in primary pulmonary hypertension.
    Klinke WP; Gilbert JA
    N Engl J Med; 1980 Jan; 302(2):91-2. PubMed ID: 7350437
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.
    Daoud FS; Reeves JT; Kelly DB
    Am J Cardiol; 1978 Nov; 42(5):817-22. PubMed ID: 707294
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral hydralazine therapy for primary pulmonary hypertension.
    Rubin LJ; Peter RH
    N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoproterenol in primary pulmonary hypertension.
    Pantano JA
    N Engl J Med; 1980 Apr; 302(16):919-20. PubMed ID: 7360180
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term favourable effect of nifedipine in primary pulmonary hypertension. Report of a case with hemodynamic evaluation after 3 and after 16 months and with clinical follow-up during 36 months.
    Musante R; Di Donato M
    G Ital Cardiol; 1985 Nov; 15(11):1110-2. PubMed ID: 3830769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and tolerance of diltiazem in primary pulmonary hypertension. Apropos of a case].
    Romanò M; Spinelli A; Beretta F; Berni F; Rho B; Muzio L
    G Ital Cardiol; 1987 Jul; 17(7):617-20. PubMed ID: 3678714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive evaluation of acute effects of oral diltiazem in primary pulmonary hypertension--a preliminary study.
    Misra M; Bajaj V; Kumar N; Puri VK
    Indian Heart J; 1986; 38(2):114-7. PubMed ID: 3557502
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.
    Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; Gibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA
    Eur Heart J; 2004 Mar; 25(5):431-6. PubMed ID: 15033256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
    Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
    N Engl J Med; 2000 Jun; 342(25):1866-70. PubMed ID: 10861321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit.
    Jackson G; Chambers J
    Int J Clin Pract; 2002 Jun; 56(5):397-8. PubMed ID: 12137450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of nicorandil in patients with primary pulmonary arterial hypertension.
    Yadav R; Anandaraja S; Bhargava B; Jindal R; Goswami KC
    Indian Heart J; 2005; 57(6):666-9. PubMed ID: 16521635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term vardenafil therapy improves hemodynamics in patients with pulmonary hypertension.
    Aizawa K; Hanaoka T; Kasai H; Kogashi K; Kumazaki S; Koyama J; Tsutsui H; Yazaki Y; Watanabe N; Kinoshita O; Ikeda U
    Hypertens Res; 2006 Feb; 29(2):123-8. PubMed ID: 16755146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.